Production & Manufacturing
Fine & Speciality Chemicals
Search Results: Fine & Speciality Chemicals
1-15 of 860 results
Almac Group Announces Successful MHRA Inspection at Charnwood Facilities
- Almac Group, the Craigavon based global contract pharmaceutical development and manufacturing organisation, is pleased to announce the successful inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its new Pharmaceutical Development & Manufacturing facilities at Charnwood Campus, Loughborough.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Almac Pod™ – Changing the Global Dynamics of Temperature Controlled Shipping Solutions
Almac Group, the global contract development and manufacturing organisation, has recognised the need for a change in dynamics of temperature controlled shipping with the launch of its new Almac Pod™ service solution in the United States.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Sanofi CEPiA - Suppliers of APIs, Custom Synthesis and Pharmaceutical Contract Manufacturing
CEPiA (Commercial & External Partnership, Industrial Affairs) is an organization fully dedicated to third-party activities within the industrial affairs of Sanofi.
Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
Almac Group Leads Economic Growth in Pennsylvania and the U.S.
Almac Group, the global contract development and manufacturing organisation, receives the spotlight for its long-term commitment to expanding its footprint in the greater Philadelphia region.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Almac Discovery Announce ALM201 Poster Presentation at 2017 European Society for Medical Oncology Congress
Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, will present highlights of the safety data from the ALM201 Phase I trial at the ESMO congress in Madrid, Spain on September 8 – 12 2017.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Lismore Comprehensive Represent Northern Ireland in Young Enterprise UK final
A group of innovative pupils from Lismore Comprehensive is representing Northern Ireland in London this week as they pitch their novel product in the UK final of the Young Enterprise Company of the Year competition.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
“Portadown Gets Active” A scheme to support local children and end holiday hunger
Children in Northern Ireland has just launched a scheme to support local children in Portadown. The programme is being delivered in partnership with the community and voluntary sector, statutory agencies, local schools and local government with additional support from Craigavon based Almac Group.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
Almac Group Announce US Workshops Targeting EU Product Launch Best Practices
Almac Group, the global contract development and manufacturing organisation, is delighted to announce two free, one-day exclusive knowledge sharing events titled "Almac Product Launch Workshop" on Tuesday, September 26th at the Andaz Hotel in San Diego, CA and on Thursday, September 28th at the DoubleTree by Hilton Hotel, Downtown Boston, MA.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases
ALMAC: Innovative Electronic Patient Identification System: Reducing burden while improving site selection and study forecasts
In recent years, the clinical development function has been adopting software tools to improve productivity and speed study timelines. Yet, there are still pockets of opportunity for manual tasks to be automated and for paperwork to be digitised.
Production & Manufacturing > Fine & Speciality Chemicals > Case Studies
Almac Discovery is Granted Orphan Drug Designation for ALM201 Programme in Ovarian Cancer
Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its drug candidate ALM201 in the treatment of ovarian cancer.
Production & Manufacturing > Fine & Speciality Chemicals > Press Releases

PBR Supplier Recommendations

Sanofi CEPiA - Suppliers of APIs, Custom Synthesis and Pharmaceutical Contract Manufacturing
CEPiA (Commercial & External Partnership, Industrial Affairs) is an organization fully dedicated to third-party activities within the industrial affairs of Sanofi. ... Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
WeylChem Group of Companies. Better chemistry – achieving more.
WeylChem Group of Companies (WCGC) was established in 2005 as the Fine Chemicals platform of International Chemical Investors Group (ICIG), a privately owned industrial holding company. We are a specialised service provider to the agrochemical, pharmaceutical, polymer and specialty chemicals industries, offering custom-, toll-manufacturing as well as advanced intermediates, reagents and performance products.... Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
See more

PBR White Paper Recommendations

Sanofi CEPiA Product List By Sanofi CEPiA Production & Manufacturing > Fine & Speciality Chemicals > White Papers Production of Biologics out of Traditional Expression Systems By Sanofi CEPiA
Within Sanofi Industrial Affairs we can offer external partners looking for a CDMO / CMO (contract development and manufacturing organization / contract manufacturing organization) the excellence of our industrial network to produce custom APIs. We are able to provide customers with GMP material from clinical stage to commercial scale.... Production & Manufacturing > Fine & Speciality Chemicals > White Papers Highly Active Pharmaceutical Ingredients By Sanofi CEPiA
A key activity is the manufacturing of highly active pharmaceutical ingredients (HAP) and cytotoxic compounds. This activity stems from Sanofi’s expertise gained through the manufacturing of taxanes (Docetaxel, Taxotere® and Cabazitaxel, Jevtana®) and in the development of other drugs for oncology. CEPiA is glad to present to customers its dedicated equipment and facilities for highly active products manufacturing.... Production & Manufacturing > Fine & Speciality Chemicals > White Papers Peptides and Oligonucleotides By Sanofi CEPiA
From a unique state-of-the-art platform for development and scale-up of Peptides and Oligonucleotides, CEPiA offers customised manufacturing and analytical services and development activities from clinical phase, up to submission and launch, as well as regulatory support and commercial supplies.... Production & Manufacturing > Fine & Speciality Chemicals > White Papers See more
1-15 of 860 results